Northern Ireland pharmaceutical group, Galen, has appointed Mr Tom Lynch, finance director of the Dublin-based Elan group, to its board of directors. Mr Lynch's appointment follows on from Galen's acquisition of Warner Chilcott in the US. Mr Lynch was a founder of that company and served as a board member until the acquisition by Galen in September. Elan is also a shareholder in Galen, holding 3.82 per cent.